NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Announces Creation of New Center of Innovation and R&D Excellence
PRESS RELEASE Simultaneous creation of Global Lab Center of Excellence IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS – 17 April 2019 – Agendia, Inc., a world leader in precision oncology, announced today that it has created Read More
Positive Assessment Issued for Agendia’s MammaPrint®
PRESS RELEASE Determination finds that Agendia’s MammaPrint® Breast Cancer Risk of Recurrence test improves net health outcome for patients and positions the test well for further adoption by health insurance plans in the U.S. IRVINE, Read More
New Studies Show MammaPrint® and BluePrint® Tests Provide Greater Clarity Regarding Risk of Breast Cancer Recurrence and Classifications for Treatment
PRESS RELEASE New Studies Show MammaPrint® and BluePrint® Tests Provide Greater Clarity Regarding Risk of Breast Cancer Recurrence and Classifications for Treatment BluePrint reclassified 85 percent of tumors identified as HER2-amplified by IHC/FISH to non-HER2 Read More